NCT02950428View on ClinicalTrials.gov

ACURATE Neo™ TA Delivery System in Patient With Severe Aortic Stenosis

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 18, 2015

Primary Completion Date

April 17, 2017

Study Completion Date

September 3, 2021

Conditions
Aortic Stenosis
Interventions
DEVICE

ACURATE neo™TA Delivery System

ACURATE neo™ Aortic Bioprosthesis and ACURATE neo™TA Transapical Delivery System on patients with severe aortic stenosis where conventional aortic valve replacement (AVR) via open-heart surgery is considered to be high risk

Trial Locations (7)

13353

Deutsched Herzzentrum Berlin, Berlin

20246

Universitätklinikum Hamburg Eppendorf, Hamburg

32545

Krankenhausbetriebsgesellschaft, Bad Oeynhausen

61231

Kerckhoff-Klinik, Bad Nauheim

93053

University Hospital Regensburg, Regensburg

06112

Martin Luther University Halle Winttenberg, Halle

04289

Herzentrum Leipzig GmbH, Leipzig

All Listed Sponsors
lead

Symetis SA

INDUSTRY

NCT02950428 - ACURATE Neo™ TA Delivery System in Patient With Severe Aortic Stenosis | Biotech Hunter | Biotech Hunter